CN106318880B - One bacillus amyloliquefaciens, bacteriostatic agent prepared therefrom and purposes - Google Patents

One bacillus amyloliquefaciens, bacteriostatic agent prepared therefrom and purposes Download PDF

Info

Publication number
CN106318880B
CN106318880B CN201510330551.9A CN201510330551A CN106318880B CN 106318880 B CN106318880 B CN 106318880B CN 201510330551 A CN201510330551 A CN 201510330551A CN 106318880 B CN106318880 B CN 106318880B
Authority
CN
China
Prior art keywords
bacillus amyloliquefaciens
vibrio
aeromonas
positive
microbial inoculum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510330551.9A
Other languages
Chinese (zh)
Other versions
CN106318880A (en
Inventor
刘志培
高喜燕
刘缨
苗莉莉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Microbiology of CAS
Original Assignee
Institute of Microbiology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Microbiology of CAS filed Critical Institute of Microbiology of CAS
Priority to CN201510330551.9A priority Critical patent/CN106318880B/en
Publication of CN106318880A publication Critical patent/CN106318880A/en
Application granted granted Critical
Publication of CN106318880B publication Critical patent/CN106318880B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to a bacillus amyloliquefaciens (Bacillus amyloliquefaciens) V4, are preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, and deposit number is CGMCC NO.10149.Bacillus amyloliquefaciens V4 bacterial strain and/or microbial inoculum provided by the invention can produce the bacteriocin of antagonism vibrio pathogen and pathogenicity Aeromonas at a temperature of the common nursery of breeding water body and cultivation; inhibit the growth and breeding of Vibrio vulnificus, Vibrio natriegen, Vibrio harveyi, Black Sea vibrios, Aeromonas hydrophila and aeromonas salmonicida; it can play the role of efficiently controlling the generation and sprawling of the infectious disease of aquatic animal as caused by vibrio pathogen and pathogenicity Aeromonas; the death rate and feed coefficient for reducing aquatic livestock, promote the weight gain of aquatic livestock.

Description

One bacillus amyloliquefaciens, bacteriostatic agent prepared therefrom and purposes
Technical field
The invention belongs to microorganism fields, more particularly, to a bacillus amyloliquefaciens, bacteriostatic agent prepared therefrom And purposes.
Background technique
China is world aquaculture big country, year cultured output account for the 71% of Gross World Product up to more than 5,000 ten thousand tons.But The lost units as caused by aquatic products disease accounts for 15% or more every year, and economic loss is up to 150,000,000,000 yuan.Known aquaculture disease Evil has more than 100 kinds, and cause of disease type has more than 300 kinds, wherein bacterial pathogen type accounts for 54.9%.And kinds of pathogenic vibrio, kill salmon gas Monad is most important pathogen in infectious disease of aquatic animal.The disease as caused by vibrios, popular area is wide, disease incidence Height causes significant damage to aquaculture.Vibrio anguillarum (Vibrio anguillarum), Vibrio harveyi (V.harveyi), wound Fish diseases can be caused by hurting a variety of vibrios such as vibrios (V.vulnificus), Vibrio salmonicida (V.salmonicida), certain Type also results in people or the morbidity of other animals.In addition, aeromonas salmonicida (Aeromonas salmonicida), thermophilic aqueous vapor Monad (Aeromonas hydrophila) is also the common pathogen of aquiculture animal.Aeromonas salmonicida Furunculosis occurs for (Aeromonas salmonicida) main infection salmon fishes.Aeromonas hydrophila (Aeromonas Hydrophila), infection leads to fulminant hemorrhage in production.
Broad-spectrum antibiotic is mainly used in aquatic animal disease prevention and treatment at present, according to expert investigation, the annual production of China is anti- Raw about 210,000 tons of raw material of element accounts for antibiotic gross annual output amount wherein there is 9.7 ten thousand tons of antibiotic for animal husbandry and fishery aquaculture 46.1%.Although the generation and sprawling of cultivated animals disease can be efficiently controlled using antibiotic, deposit in actual production Abuse of antibiotics in blindness use and drug abuse phenomenon, aquaculture has various negative effects.First, antibiotic Blindness using beneficial microorganism normal growth and breeding in severe jamming breeding environment and aquatic livestock enteron aisle, destroy micro- The ecological balance.Second, in aquaculture, long-term a large amount of, the nonstandard use of antibiotic causes aquatic livestock to pathogenic microorganism Neurological susceptibility, more seriously cause the drug resistance of pathogen to enhance, a large amount of drug-resistant bacterias, even superbacteria occur.Third, The use of antibiotic also results in it and remains, is enriched in aquatic animal body, will finally endanger the health of the mankind.Although aquatic products The residual quantity of middle antibiotic is very low, but very serious to the potential hazard of human health, and has a far reaching influence.4th, antibiotic Medicament residue also results in aquatic product quality reduction, becomes the limiting factor of aquatic products sales volume and export trade amount.
Probiotics are one of existing antibiotic and the most effective substitute products of synthetic drug species feed addictive, are had The characteristics of manufacturing cost is low, mature technology, thus it should be able to it is superior with its, be conducive to human health and ecological ring The properties of product of border protection, gradually substitute antibiotics.In breeding production the probiotics of practical application include: viable bacteria body, it is dead The parts such as thallus, drive member, metabolite and active growth helping matter.Thus, it is found that new can be applied to water The bacterial strain for producing the probiotics of cultivation is of great significance.
Summary of the invention
The present invention provides a bacillus amyloliquefaciens (Bacillus amyloliquefaciens) V4, the bacterial strain, It can inhibit the growth and breeding of vibrio pathogen and pathogenicity Aeromonas, moved to reduce the aquatic products as caused by these pathogens The generation and sprawling of object communicable disease, reduce the death rate of aquatic livestock.
One aspect of the present invention provides a bacillus amyloliquefaciens (Bacillus amyloliquefaciens) V4, the bacterial strain are deposited in China Committee for Culture Collection of Microorganisms's common micro-organisms center on December 10th, 2014, Deposit number is CGMCC No.10149.Depositary institution address: Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3.
The bacillus amyloliquefaciens, are isolated from ocean circulating water cultivation environment, which has characteristics that
Colonial morphology of the bacterial strain on 2216E culture medium are as follows: white, translucent, smooth wet bacterium colony slightly swells, round Neat bacterium colony;Gram's staining thallus purple is gram-positive bacteria, rod-shaped;Alkaline phosphatase experiment is positive;Naphthols-AS-BI Phosphohydrolase experiment is negative;Alpha-glucosidase experiment is positive;Carbohydrate experiment: mannitol is positive;L-arabinose It is positive;D-ribose is positive;D- xylose is positive;D-Glucose is positive;D-Fructose is positive;D-MANNOSE is positive;Inositol is positive;Sweet dew Sugar alcohol is positive;Sorbierite is positive;Methyl-α D- glucopyranoside is positive;N-Acetyl-D-glucosamine is positive;Amarogentin is positive; ARBULIN is positive;Aesculin ironic citrate is positive;Salicin is positive;D- cellobiose is positive;D-Maltose is positive;D- lactose It is positive;D- melibiose is positive;D- sucrose is positive;D- trehalose is positive;D- raffinose is positive;Starch is positive;Glycogen is positive;Xylose Alcohol is positive;D- gentiobiose is positive;The Toulon D- sugar is positive;K-IAO is positive.
Another aspect of the present invention, provide above-described bacillus amyloliquefaciens V4 inhibit vibrio pathogen and The purposes of the growth of pathogenicity Aeromonas and/or breeding.
In the above-mentioned technical solutions, the vibrio pathogen includes Vibrio vulnificus, Vibrio natriegen, Vibrio harveyi and Black Sea Vibrios, the pathogenicity Aeromonas includes Aeromonas hydrophila and aeromonas salmonicida.
The present invention also provides a kind of bacteriostatic agent, active constituent is above-described bacillus amyloliquefaciens (Bacillus amyloliquefaciens)V4。
The preparation method of above-mentioned bacteriostatic agent, includes the following steps:
By above-described bacillus amyloliquefaciens (Bacillus amyloliquefaciens) V4 access LB liquid training It supports and is cultivated in base, condition of culture is 28~32 DEG C of temperature, 180~210rpm of hunting speed, incubation time 1~3 day, the training of acquisition Nutrient solution, that is, the bacteriostatic agent.
Preferably, cultivation temperature is 30 DEG C, hunting speed 200rpm, incubation time 2 days.
In the above-mentioned technical solutions, the LB culture medium includes following ingredient: 8~12 mass parts of peptone, and yeast extracts 4~6 mass parts of object and/or yeast extract, 8~12 mass parts of sodium chloride, 970~980 mass parts of distilled water, NaOH tune pH 7~ 7.5。
Preferably, 10 mass parts of peptone, 5 mass parts of yeast extract and/or yeast extract, 10 mass parts of sodium chloride, 975 mass parts of distilled water, with NaOH tune pH 7.2.
Another aspect of the invention provides a kind of prevention and/or killing aquatic products vibrio pathogen and aquatic products pathogenicity gas The method of monad accesses above-described bacteriostatic agent into water body.
In the above-mentioned technical solutions, the vibrio pathogen includes Vibrio vulnificus, Vibrio natriegen, Vibrio harveyi and Black Sea Vibrios, the pathogenicity Aeromonas includes Aeromonas hydrophila and aeromonas salmonicida.
It is still another aspect of the present invention to provide a kind of reduction aquatic livestock death rate and feed coefficient, improve rate of body weight gain Method accesses above-described bacteriostatic agent into aquaculture of aquatic animal water body by 0.1%~0.3% volume ratio.
Bacillus amyloliquefaciens V4 bacterial strain and/or microbial inoculum provided by the invention are in the common nursery of breeding water body and cultivation temperature The lower bacteriocin that can produce antagonism vibrio pathogen and pathogenicity Aeromonas of degree, inhibits Vibrio vulnificus, Vibrio natriegen, Ha Wei The growth and breeding of family name vibrios, Black Sea vibrios, Aeromonas hydrophila and aeromonas salmonicida, can play and efficiently control by disease The effect of generation and the sprawling of infectious disease of aquatic animal caused by originality vibrios and pathogenicity Aeromonas, reduces aquatic products The death rate of animal promotes the weight gain of aquatic livestock.
Detailed description of the invention
The inhibition that Fig. 1 bacillus amyloliquefaciens V4 microbial inoculum supernatant grows Vibrio vulnificus (Vibrio vulnificus);
The inhibition that Fig. 2 bacillus amyloliquefaciens V4 microbial inoculum supernatant grows Vibrio natriegen (Vibrio natriegens);
Fig. 3 bacillus amyloliquefaciens V4 microbial inoculum supernatant grows Aeromonas hydrophila (Aeromonas hydrophila) Inhibition;
Fig. 4 bacillus amyloliquefaciens V4 microbial inoculum supernatant is raw to aeromonas salmonicida (Aeromonas salmonicida) Long inhibition;
The suppression that Fig. 5 bacillus amyloliquefaciens V4 microbial inoculum supernatant grows Vibrio harveyi (Vibrio harveyi PH4) System;
The inhibition that Fig. 6 bacillus amyloliquefaciens V4 microbial inoculum supernatant grows Black Sea vibrios (Vibrio ponticus).
Specific embodiment
Below in conjunction with drawings and examples, a specific embodiment of the invention is described in more details, so as to energy The advantages of enough more fully understanding the solution of the present invention and its various aspects.However, specific embodiments described below and reality It applies example to be for illustrative purposes only, rather than limiting the invention.
The species identification of 1 bacterial strain of embodiment
Biological characteristics: colonial morphology of the bacterial strain on 2216E culture medium are as follows: white, translucent, smooth wet bacterium colony, It slightly swells, round neat bacterium colony;Gram's staining thallus purple is gram-positive bacteria, rod-shaped;Alkaline phosphatase experiment sun Property;The experiment of naphthols-AS-BI phosphohydrolase is negative;Alpha-glucosidase experiment is positive;Carbohydrate experiment: mannitol sun Property;L-arabinose is positive;D-ribose is positive;D- xylose is positive;D-Glucose is positive;D-Fructose is positive;D-MANNOSE is positive; Inositol is positive;Mannitol is positive;Sorbierite is positive;Methyl-α D- glucopyranoside is positive;N-Acetyl-D-glucosamine is positive; Amarogentin is positive;ARBULIN is positive;Aesculin ironic citrate is positive;Salicin is positive;D- cellobiose is positive;D- malt It is sugared positive;D- Lactose-positive;D- melibiose is positive;D- sucrose is positive;D- trehalose is positive;D- raffinose is positive;Starch is positive; Glycogen is positive;Xylitol is positive;D- gentiobiose is positive;The Toulon D- sugar is positive;K-IAO is positive.
Molecular biology identification: the acquisition process of 16S rRNA gene and the comparison result with existing strain in sequence table
It is cultivated in bacterial strain V4 access LB liquid medium, condition of culture is 28~32 DEG C of temperature, hunting speed 180~ 210rpm incubation time 24 hours, takes 1ml liquid medium in 1.5ml centrifuge tube, and 8000r/min is centrifuged 5min, abandons supernatant 500 μ l ddH are added in liquid2Cell is resuspended in O, and cell suspension 8000r/min is centrifuged 5min, abandons supernatant, 100 μ l are added ddH2Cell is resuspended in O, then centrifuge tube is put into boiling water and boils 10min, makes cell cracking, takes after 8000r/min centrifugation 5min Clear 2 μ l expands the 16S of the bacterial strain using 27F, 1492R as upstream and downstream primer as pcr template in 50 μ l reaction systems RRNA gene.Shown in the 16S rRNA sequence SEQ ID NO:1 for obtaining V4 bacterial strain after gene sequencing.
It is searched in the databases such as the GenBank of NCBI (http://www.ncbi.nlm.nih.gov/BLAST/) close The 16S rRNA gene order of bacterial strain carries out multisequencing contraposition arrangement with MEGA software, using Neighbor-Joining method structure Phylogenetic tree is built, it is as follows.
2 bacillus amyloliquefaciens V4 microbial inoculum supernatant of embodiment is raw to Vibrio vulnificus CZ-A2 (Vibrio vulnificus) Long inhibition
1. the preparation of bacillus amyloliquefaciens V4 microbial inoculum supernatant:
By in the LB culture medium of bacillus amyloliquefaciens V4 strain inoculated to 100mL, 30 DEG C of cultures obtain microbial inoculum for 24 hours, will Microbial inoculum 8000r/min is centrifuged 10 minutes, obtains microbial inoculum supernatant, which is obtained by filtration nothing with disposable syringe filter Fermented liquid.
LB medium component: 10 mass parts of peptone, 5 mass parts of yeast extract, 10 mass parts of sodium chloride, distilled water 975 Mass parts, pH 7.2.
2. the inhibiting effect that microbial inoculum supernatant grows Vibrio vulnificus (Vibrio vulnificus) CZ-A2:
Vibrio vulnificus (Vibrio vulnificus) CZ-A2 is prepared into bacteria suspension, it is flat that 100 μ l bacteria suspensions are coated with LB solid The aseptic filter paper piece of diameter 6mm is placed in planar surface by plate, and the bacillus amyloliquefaciens V4 without fermented liquid of 10 μ l is added dropwise in nothing On bacterium filter paper, then culture dish is placed in 30 DEG C of incubators and is cultivated 24 hours.Visible bacillus amyloliquefaciens V4 is observed to wound Hurt the inhibition zone of vibrios generation, inhibition zone area is 220.71 ± 6.61mm2(attached drawing 1).
Embodiment 3, bacillus amyloliquefaciens V4 microbial inoculum supernatant are to Vibrio natriegen (Vibrio natriegens FS-1) The inhibition of growth
1. the preparation of bacillus amyloliquefaciens V4 microbial inoculum supernatant:
Bacillus amyloliquefaciens V4 microbial inoculum supernatant is made by step 1 in embodiment 2.
2. the inhibiting effect that microbial inoculum supernatant grows Vibrio natriegen (Vibrio natriegens FS-1):
Vibrio natriegen (Vibrio natriegens) is prepared into bacteria suspension, 100 μ l bacteria suspensions are coated with LB solid plate, will The aseptic filter paper piece of diameter 6mm is placed in planar surface, and the bacillus amyloliquefaciens V4 without fermented liquid of 10 μ l is added dropwise in sterile filter On the scraps of paper, then culture dish is placed in 30 DEG C of incubators and is cultivated 24 hours.Visible bacillus amyloliquefaciens V4 is observed to needing sodium arc The inhibition zone that bacterium generates, inhibition zone area are 50.24 ± 3.6mm2(attached drawing 2).
Embodiment 4, bacillus amyloliquefaciens V4 microbial inoculum supernatant are to Aeromonas hydrophila (Aeromonas Hydrophila) the inhibition grown
1. the preparation of bacillus amyloliquefaciens V4 microbial inoculum supernatant:
Bacillus amyloliquefaciens V4 microbial inoculum supernatant is made by step 1 in embodiment 2.
2. the inhibiting effect that microbial inoculum supernatant grows Aeromonas hydrophila (Aeromonas hydrophila):
Aeromonas hydrophila (Aeromonas hydrophila) is prepared into bacteria suspension, 100 μ l bacteria suspensions are coated with LB solid The aseptic filter paper piece of diameter 6mm is placed in planar surface by plate, be added dropwise the bacillus amyloliquefaciens V4 without fermented liquid of 10 μ l in Aseptic filter paper on piece, then culture dish is placed in 30 DEG C of incubators and is cultivated 24 hours.Observe V4 pairs of visible bacillus amyloliquefaciens The raw inhibition zone of Aeromonas hydrophila, inhibition zone area are 176.625 ± 5.18mm2(attached drawing 3).
Embodiment 5, bacillus amyloliquefaciens V4 microbial inoculum supernatant are to aeromonas salmonicida (Aeromonas Salmonicida) the inhibition grown
1. the preparation of bacillus amyloliquefaciens V4 microbial inoculum supernatant:
Bacillus amyloliquefaciens V4 microbial inoculum supernatant is made by step 1 in embodiment 2.
2. the inhibiting effect that microbial inoculum supernatant grows aeromonas salmonicida (Aeromonas salmonicida):
Aeromonas salmonicida (Aeromonas salmonicida) is prepared into bacteria suspension, 100 μ l bacteria suspensions are coated with LB solid The aseptic filter paper piece of diameter 6mm is placed in planar surface by plate, be added dropwise the bacillus amyloliquefaciens V4 without fermented liquid of 10 μ l in Aseptic filter paper on piece, then culture dish is placed in 30 DEG C of incubators and is cultivated 24 hours.Observe V4 pairs of visible bacillus amyloliquefaciens The inhibition zone that aeromonas salmonicida generates, inhibition zone area are 240.41 ± 4.57mm2(attached drawing 4).
Embodiment 6, bacillus amyloliquefaciens V4 microbial inoculum supernatant are raw to Vibrio harveyi (Vibrio harveyi PH4) Long inhibition
1. the preparation of bacillus amyloliquefaciens V4 microbial inoculum supernatant:
Bacillus amyloliquefaciens V4 microbial inoculum supernatant is made by step 1 in embodiment 2.
2. the inhibiting effect that microbial inoculum supernatant grows Vibrio harveyi (Vibrio harveyi PH4):
Vibrio harveyi (Vibrio harveyi PH4) is prepared into bacteria suspension, 100 μ l bacteria suspensions are coated with LB solid plate, The aseptic filter paper piece of diameter 6mm is placed in planar surface, the bacillus amyloliquefaciens V4 without fermented liquid of 10 μ l is added dropwise in sterile On filter paper, then culture dish is placed in 30 DEG C of incubators and is cultivated 24 hours.Visible bacillus amyloliquefaciens V4 is observed to tie up Kazakhstan The inhibition zone that family name vibrios generates, inhibition zone area are 47.78 ± 4.62mm2(attached drawing 5).
The suppression that embodiment 7, bacillus amyloliquefaciens V4 microbial inoculum supernatant grow Black Sea vibrios (Vibrio ponticus) System
1. the preparation of bacillus amyloliquefaciens V4 microbial inoculum supernatant:
Bacillus amyloliquefaciens V4 microbial inoculum supernatant is made by step 1 in embodiment 2.
2. the inhibiting effect that microbial inoculum supernatant grows Black Sea vibrios (Vibrio ponticus B8):
Black Sea vibrios (Vibrio ponticus B8) is prepared into bacteria suspension, 100 μ l bacteria suspensions are coated with LB solid plate, will The aseptic filter paper piece of diameter 6mm is placed in planar surface, and the bacillus amyloliquefaciens V4 without fermented liquid of 10 μ l is added dropwise in sterile filter On the scraps of paper, then culture dish is placed in 30 DEG C of incubators and is cultivated 24 hours.Visible bacillus amyloliquefaciens V4 is observed to Black Sea arc The inhibition zone that bacterium generates, inhibition zone area are 63.59 ± 2.9mm2(attached drawing 6).
The influence of embodiment 8, addition different proportion bacillus amyloliquefaciens V4 microbial inoculum to rainbow trout growth and survival
1. the preparation of bacillus amyloliquefaciens V4 microbial inoculum
By in the LB liquid medium of ingredient described in bacillus amyloliquefaciens V4 strain inoculated to embodiment 2,30 DEG C are trained It supports for 24 hours, gained culture solution is bacillus amyloliquefaciens V4 microbial inoculum.
2. adding different proportion bacillus amyloliquefaciens V4 preparation in Donaldson rainbow trout aquaculture pond
0.1%~0.3% ratio adds bacillus amyloliquefaciens V4 preparation into Donaldson rainbow trout aquaculture pond by volume, if Control group is set, original body mass, latter stage weight, rate of body weight gain, feed coefficient, specific growth rate and the death rate of Donaldson rainbow trout are monitored. After cultivation 45 days, compared with the control group, addition group can promote the weight gain of Donaldson rainbow trout, and promoting ratio is 17.08~71.22%. Feed coefficient can be reduced simultaneously, highest rate is up to 19.49%.Meanwhile compared with the control group, addition group can reduce Donaldson rainbow trout The death rate, ratio are 27.25~81.86% (being shown in Table 1).
Table 1

Claims (6)

1. a bacillus amyloliquefaciens (Bacillus amyloliquefaciens) V4 is preserved in Chinese microorganism strain guarantor Administration committee's common micro-organisms center is hidden, deposit number is CGMCC NO.10149.
2. bacillus amyloliquefaciens V4 described in claim 1 inhibits vibrio pathogen and the growth of pathogenicity Aeromonas in preparation And/or the purposes of breeding drug.
3. purposes as claimed in claim 2, which is characterized in that the vibrio pathogen includes Vibrio vulnificus, Vibrio natriegen, Kazakhstan Vickers vibrios and Black Sea vibrios, the pathogenicity Aeromonas includes aeromonas salmonicida.
4. a kind of bacteriostatic agent, which is characterized in that its active constituent is bacillus amyloliquefaciens described in claim 1 (Bacillus amyloliquefaciens)V4。
5. the preparation method of bacteriostatic agent as claimed in claim 4, which comprises the steps of:
By bacillus amyloliquefaciens described in claim 1 (Bacillus amyloliquefaciens) V4 access LB liquid training It supports and is cultivated in base, condition of culture is 28~32 DEG C of temperature, 180~210rpm of hunting speed, incubation time 1~3 day, the training of acquisition Nutrient solution, that is, the bacteriostatic agent.
6. preparation method as claimed in claim 5, which is characterized in that the LB culture medium includes following ingredient: peptone 8~ 12 mass parts, 4~6 mass parts of yeast extract and/or yeast extract, 8~12 mass parts of sodium chloride, 970~980 matter of distilled water Measure part, NaOH tune pH 7~7.5.
CN201510330551.9A 2015-06-15 2015-06-15 One bacillus amyloliquefaciens, bacteriostatic agent prepared therefrom and purposes Active CN106318880B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510330551.9A CN106318880B (en) 2015-06-15 2015-06-15 One bacillus amyloliquefaciens, bacteriostatic agent prepared therefrom and purposes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510330551.9A CN106318880B (en) 2015-06-15 2015-06-15 One bacillus amyloliquefaciens, bacteriostatic agent prepared therefrom and purposes

Publications (2)

Publication Number Publication Date
CN106318880A CN106318880A (en) 2017-01-11
CN106318880B true CN106318880B (en) 2019-09-20

Family

ID=57732587

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510330551.9A Active CN106318880B (en) 2015-06-15 2015-06-15 One bacillus amyloliquefaciens, bacteriostatic agent prepared therefrom and purposes

Country Status (1)

Country Link
CN (1) CN106318880B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106544309B (en) * 2017-01-17 2019-05-31 华南师范大学 One bacillus amyloliquefaciens and its antibacterial protein and the application in prawn is fresh-keeping
CN107227324A (en) * 2017-08-07 2017-10-03 天津科技大学 A kind of glutamic acid fermentation technique
CN107937301B (en) * 2017-11-08 2020-04-07 青岛农业大学 Bacillus amyloliquefaciens and application thereof in aquaculture
US20210084905A1 (en) * 2018-02-19 2021-03-25 President And Fellows Of Harvard College Methods and compositions for aquaculture
CN108220209A (en) * 2018-03-26 2018-06-29 宁波大学 A kind of binary composite bacteria agent used for aquiculture
CN110396482B (en) * 2019-04-30 2021-02-19 江苏好润生物产业集团股份有限公司 Antagonistic bacterium bacillus amyloliquefaciens X8 strain and application thereof
CN111040975B (en) * 2020-01-03 2021-10-15 广东省微生物研究所(广东省微生物分析检测中心) Enzyme-producing bacillus halophilus and application thereof in preventing and controlling pathogenic bacteria in saline water aquaculture
CN111635878B (en) * 2020-07-24 2022-05-10 宁波大学 Bacillus amyloliquefaciens and application thereof in pomfret culture
CN111849825B (en) * 2020-07-29 2022-03-04 黄河三角洲京博化工研究院有限公司 Vibrio cholerae antagonistic strain and application thereof
CN113005054B (en) * 2021-02-04 2022-07-12 江苏海洋大学 Bacillus amyloliquefaciens SS-ZC-26 and preparation method and application thereof
CN114716030B (en) * 2022-04-29 2022-11-22 哈尔滨工业大学(深圳) Spherical hydrogel and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103045498A (en) * 2012-10-10 2013-04-17 浙江大学 Bacillus amyloliquefaciens and application thereof
CN103173397A (en) * 2013-04-02 2013-06-26 山东省农业科学院农产品研究所 Broad-spectrum antibacterial bacillus amyloliquefaciens strain and application thereof
CN103320365A (en) * 2013-07-09 2013-09-25 中国水产科学研究院淡水渔业研究中心 Fish-sourced aeromonas hydrophila disease antagonistic strain and application thereof
CN104195067A (en) * 2014-07-07 2014-12-10 中国水产科学研究院南海水产研究所 Bacillus amyloliquefaciens and application thereof in aquaculture

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103045498A (en) * 2012-10-10 2013-04-17 浙江大学 Bacillus amyloliquefaciens and application thereof
CN103173397A (en) * 2013-04-02 2013-06-26 山东省农业科学院农产品研究所 Broad-spectrum antibacterial bacillus amyloliquefaciens strain and application thereof
CN103320365A (en) * 2013-07-09 2013-09-25 中国水产科学研究院淡水渔业研究中心 Fish-sourced aeromonas hydrophila disease antagonistic strain and application thereof
CN104195067A (en) * 2014-07-07 2014-12-10 中国水产科学研究院南海水产研究所 Bacillus amyloliquefaciens and application thereof in aquaculture

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
抗嗜水气单胞菌解淀粉芽孢杆菌的抗菌机理研究及其微胶囊制剂的安全性评价;曹海鹏;《中国博士学位论文全文数据库农业科技辑》;20140515;D052-9 *

Also Published As

Publication number Publication date
CN106318880A (en) 2017-01-11

Similar Documents

Publication Publication Date Title
CN106318880B (en) One bacillus amyloliquefaciens, bacteriostatic agent prepared therefrom and purposes
CN103614327B (en) A kind of subtilis and uses thereof
CN103160455B (en) Preparation method of spore preparation of bacillus coagulans
CN101690545B (en) Method for producing complex micro-ecological preparation with microbial agents and enzyme
CN103981118B (en) A kind of bacillus subtilis feed addictive and its preparation method and application
CN108865953A (en) One plant of wide spectrum inhibits bacillus and its composite bacteria preparation of aquatic products vibrio pathogen
CN102533587B (en) Bacillus licheniformis and fungicide, feed additive and premix thereof
CN102154176B (en) Turbot pathogenic strain and inactivated vaccine for ascites disease
CN103045498B (en) Bacillus amyloliquefaciens and application thereof
CN106754551A (en) A kind of bacterium amount lactobacillus preparation high and preparation method and application
CN109749966A (en) One plant of Pseudoalteromonas and its application as probiotics on aquatic products
CN103667128A (en) Bacillus licheniformis and its use
CN103320351B (en) Lactococcus garvieae and biological feed-additive prepared therefrom
CN115505546A (en) Salt-tolerant bacillus for inhibiting aeromonas hydrophila and application thereof
CN103266074B (en) B.subtilis spores strain and application thereof
CN101869118A (en) Application of bacillus pumilus H2 in preventing and/or killing culture water vibrios
CN104388338B (en) Compound bacterium preparation and application thereof
CN101993842A (en) Vibrio alginolyticus strain and application thereof
CN104388327A (en) Microecological preparation, forage additive and premix
CN103205383B (en) Bacillus pumilus E14, culturing method thereof and application
CN107916229B (en) One plant of Inonotus obliquus and its application
CN105274032A (en) Lactobacillus reuteri antagonizing Campylobacter jejuni and inhibiting flaA gene expression of Campylobacter jejuni
CN106011037B (en) A kind of lactobacillus acidophilus and its application
CN108823135A (en) A kind of fermentation medium and fermentation condition improving ocean brown bacillus number of viable and antibacterial activity
CN110651891B (en) Probiotic preparation for improving growth performance, immunity and nutritional quality of turbot

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant